Solution for Oral Administration

COMPOSITION:Each 1 ml contains:
Bromhexine HCL 10 mg.
Bromhexine hydrochloride the active ingredient of AVIXIN M1% is a mucolytic agent which aims to make bronchial secretions easier to propel by ciliary action to expel by coughing and in this way reduce cough frequency.
AVIXIN M1% is also of value in achieving liquefaction and improved flow characteristics of mucus by increasing its volume and decreasing its viscidity. It is suggested that AVIXIN M1% (Bromhexine) improves lysosomal function and that lysosomal enzymes hydrolyse the mucopolysaccharide fibers of mucus. Bromhixine brings about an increase in the content of immunoglobulin in bronchial secretions, presumably by increasing membrane permeability.
AVIXIN M1% is indicated for the treatment of conditions of respiratory tract associated with retention of mucoid secretion such as bronchitis. It is also used as ancillary therapy in the management of bronchopenumonia in poultry, horses and cattle, as well as for the treatment of amniotic fluid aspiration in newborn animals.
Dosage and administration:
Poultry: 1 ml AVIXIN M1% per 1 liter of drinking water for 3 - 5 days.
Cattle: 2 ml AVIXIN M1% per 10 kg b.wt. for 5 - 7 days.
Horses: 2-5 ml AVIXIN M1% per 50 kg. b.wt. for 7 days.
Withdrawal period: 4 days.
Bromhexine is entirely safe and nontoxic, and can be safely used in conjunction with antibiotics & sulphonamide.
Store in a dark place at temperature below 30 º C.
100 ml, 500 ml and 1 liter plastic bottles.